153 related articles for article (PubMed ID: 37593885)
1. Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma.
Yang C; He Y; Wang Y; McKinnon PJ; Shahani V; Miller DD; Pfeffer LM
J Cell Mol Med; 2023 Sep; 27(18):2770-2781. PubMed ID: 37593885
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma.
Yang C; Wang Y; Sims MM; He Y; Miller DD; Pfeffer LM
Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577604
[TBL] [Abstract][Full Text] [Related]
3. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.
He Y; Yang C; Wang Y; Sacher JR; Sims MM; Pfeffer LM; Miller DD
Bioorg Med Chem; 2022 Jan; 53():116533. PubMed ID: 34863065
[TBL] [Abstract][Full Text] [Related]
4. The Bromodomain Inhibitor PFI-3 Sensitizes Cancer Cells to DNA Damage by Targeting SWI/SNF.
Lee D; Lee DY; Hwang YS; Seo HR; Lee SA; Kwon J
Mol Cancer Res; 2021 May; 19(5):900-912. PubMed ID: 33208498
[TBL] [Abstract][Full Text] [Related]
5. The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.
Sharma T; Robinson DCL; Witwicka H; Dilworth FJ; Imbalzano AN
Nucleic Acids Res; 2021 Aug; 49(14):8060-8077. PubMed ID: 34289068
[TBL] [Abstract][Full Text] [Related]
6. Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.
Wang Y; Yang CH; Schultz AP; Sims MM; Miller DD; Pfeffer LM
J Cell Mol Med; 2021 Mar; 25(6):2956-2966. PubMed ID: 33528916
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Wnt signaling pathway during myogenesis by the mammalian SWI/SNF ATPase BRG1.
Sharma T; Olea-Flores M; Imbalzano AN
Front Cell Dev Biol; 2023; 11():1160227. PubMed ID: 37484913
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain-containing subunits BRD1, BRD2, and BRD13 are required for proper functioning of SWI/SNF complexes in
Jarończyk K; Sosnowska K; Zaborowski A; Pupel P; Bucholc M; Małecka E; Siwirykow N; Stachula P; Iwanicka-Nowicka R; Koblowska M; Jerzmanowski A; Archacki R
Plant Commun; 2021 Jul; 2(4):100174. PubMed ID: 34327319
[TBL] [Abstract][Full Text] [Related]
9. The SWI/SNF subunit BRG1 affects alternative splicing by changing RNA binding factor interactions with nascent RNA.
Gañez-Zapater A; Mackowiak SD; Guo Y; Tarbier M; Jordán-Pla A; Friedländer MR; Visa N; Östlund Farrants AK
Mol Genet Genomics; 2022 Mar; 297(2):463-484. PubMed ID: 35187582
[TBL] [Abstract][Full Text] [Related]
10. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
[TBL] [Abstract][Full Text] [Related]
11. Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
Rago F; Rodrigues LU; Bonney M; Sprouffske K; Kurth E; Elliott G; Ambrose J; Aspesi P; Oborski J; Chen JT; McDonald ER; Mapa FA; Ruddy DA; Kauffmann A; Abrams T; Bhang HC; Jagani Z
Mol Cancer Res; 2022 Mar; 20(3):361-372. PubMed ID: 34799403
[TBL] [Abstract][Full Text] [Related]
12. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
Raab JR; Runge JS; Spear CC; Magnuson T
Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
[TBL] [Abstract][Full Text] [Related]
13. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
Zhou M; Sareddy GR; Li M; Liu J; Luo Y; Venkata PP; Viswanadhapalli S; Tekmal RR; Brenner A; Vadlamudi RK
Sci Rep; 2019 Apr; 9(1):6124. PubMed ID: 30992459
[TBL] [Abstract][Full Text] [Related]
15. Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.
Willis MS; Homeister JW; Rosson GB; Annayev Y; Holley D; Holly SP; Madden VJ; Godfrey V; Parise LV; Bultman SJ
Circ Res; 2012 Aug; 111(5):e111-22. PubMed ID: 22740088
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.
Liang H; Chen Z; Sun L
Mol Carcinog; 2019 Aug; 58(8):1502-1511. PubMed ID: 31045274
[TBL] [Abstract][Full Text] [Related]
17. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
[TBL] [Abstract][Full Text] [Related]
18. BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions
Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN
Oncoscience; 2016; 3(11-12):337-350. PubMed ID: 28105458
[TBL] [Abstract][Full Text] [Related]
19. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.
Strobeck MW; Reisman DN; Gunawardena RW; Betz BL; Angus SP; Knudsen KE; Kowalik TF; Weissman BE; Knudsen ES
J Biol Chem; 2002 Feb; 277(7):4782-9. PubMed ID: 11719516
[TBL] [Abstract][Full Text] [Related]
20. FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
Zhang N; Wu X; Yang L; Xiao F; Zhang H; Zhou A; Huang Z; Huang S
Clin Cancer Res; 2012 Nov; 18(21):5961-71. PubMed ID: 22977194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
